Cannabinoids for Autism: Clinical Evidence & ECS Research
Clinical Takeaway Cannabinoid-based treatments, particularly CBD-rich formulations, have shown early promise in reducing irritability, hyperactivity, and disruptive behaviors in individuals with autism spectrum disorder. Current evidence is limited to…
CBD Gummies and Alzheimer’s: What the Evidence Shows for Cognitive and Behavioral Support
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic…
Cannabinoids for Autism: Clinical Research Systematic Review
Clinical Takeaway CBD-based treatments, particularly cannabidiol-rich preparations, showed measurable reductions in behavioral symptoms such as hyperactivity, self-injury, and rage attacks in children with autism spectrum disorder across multiple…
Cannabis edibles in dementia care: What families should know – AZ Family
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaGeriatricsEdiblesBehavioral…
Alzheimer’s | Center for Medical Cannabis | Utah Department of Health and Human Services
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Alzheimer'SNeurodegenerationState…
Medicinal Cannabis Shows Efficacy for Alzheimer’s Palliative Care – Sechat
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Alzheimer'S DiseasePalliative…
Cannabinoids for Autism: Clinical Evidence Reviewed
Clinical Takeaway CBD-based treatments, particularly cannabidiol-rich preparations, have shown preliminary benefits for certain autism-associated behaviors such as irritability, hyperactivity, and social communication challenges in some clinical trials.…
Rigorous CBD Trial for Autism Behavioral Symptoms Launches—But Results Are Not Yet In
There is a significant need for clinical research exploring alternative medications for the treatment of behavioral symptoms of ASD. Cannabidiol (CBD) is being studied for the management of irritability, aggression, and other problem behaviors associated…
Endocannabinoid System Research: Cannabis for Autism
Clinical Takeaway Across randomized clinical trials, cannabis derivatives and their analogs showed promising early signals for improving core and associated symptoms of autism spectrum disorder, including social communication and behavioral challenges.…
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Clinical Takeaway Transdermal cannabidiol gel (ZYN002) has been studied in children and adolescents with Fragile X syndrome through an open-label extension trial focused on long-term safety and tolerability. Early interim data suggest the synthetic CBD…